Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Ultragenyx
Exclusive
Breaking News
NDSU College of Business launches new banking and finance center in Fargo – InForum
Aspira charter network at risk of closure next month
Who qualifies for permanent residence under Canada’s new Transport category?
Tokayev Meets US Business and Financial Leaders During Washington Visit
Symposium on International Investment Law & Contemporary Crises: Do Investment Treaties Accord Too Much (or Too Little) Protection to Banking and Finance Investments?